Marshall Wace, LLP Quest Diagnostics Inc Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 1,000,665 shares of DGX stock, worth $137 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,000,665

Previous 189,025 429.38%

Holding current value

$137 Million

Previous $25.9 Million 430.21%

% of portfolio

0.18%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$137.09 - $137.09 $111 Million - $111 Million	811,640 Added 429.38%	1,000,665 $137 Million
Q2 2024 Aug 14, 2024	SELL	$125.91 - $144.34 $50 Million - $57.3 Million	-397,174 Reduced 67.75%	189,025 $25.9 Million
Q1 2024 May 15, 2024	BUY	$123.78 - $142.11 $51.7 Million - $59.4 Million	417,862 Added 248.23%	586,199 $78 Million
Q4 2023 Feb 14, 2024	BUY	$120.62 - $141.12 $20.1 Million - $23.5 Million	166,348 Added 8363.4%	168,337 $23.2 Million
Q3 2023 Nov 14, 2023	BUY	$121.86 - $144.92 $242,379 - $288,245	1,989 New	1,989 $242,000
Q1 2023 May 15, 2023	SELL	$131.53 - $155.76 $11.9 Million - $14.1 Million	-90,395 Reduced 82.01%	19,827 $2.81 Million
Q4 2022 Feb 14, 2023	BUY	$123.31 - $157.26 $10.6 Million - $13.6 Million	86,337 Added 361.47%	110,222 $17.2 Million
Q3 2022 Nov 14, 2022	BUY	$121.77 - $141.1 $862,740 - $999,693	7,085 Added 42.17%	23,885 $2.93 Million
Q2 2022 Aug 15, 2022	SELL	$127.07 - $145.39 $3.94 Million - $4.51 Million	-30,991 Reduced 64.85%	16,800 $2.23 Million
Q1 2022 May 16, 2022	BUY	$129.09 - $164.35 $1.21 Million - $1.54 Million	9,389 Added 24.45%	47,791 $6.54 Million
Q4 2021 Feb 14, 2022	SELL	$140.36 - $173.01 $8.14 Million - $10 Million	-57,992 Reduced 60.16%	38,402 $6.64 Million
Q3 2021 Nov 15, 2021	BUY	$132.95 - $158.0 $109,284 - $129,876	822 Added 0.86%	96,394 $14 Million
Q2 2021 Aug 13, 2021	BUY	$126.66 - $141.48 $7.83 Million - $8.75 Million	61,828 Added 183.23%	95,572 $12.6 Million
Q1 2021 May 17, 2021	SELL	$114.63 - $133.34 $3.16 Million - $3.67 Million	-27,558 Reduced 44.95%	33,744 $4.33 Million
Q4 2020 Feb 16, 2021	BUY	$112.7 - $128.05 $6.91 Million - $7.85 Million	61,302 New	61,302 $7.31 Million
Q3 2020 Nov 16, 2020	SELL	$107.05 - $130.01 $17.2 Million - $20.9 Million	-160,517 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$73.34 - $122.61 $36.4 Million - $60.9 Million	-496,688 Reduced 75.58%	160,517 $18.3 Million
Q1 2020 May 15, 2020	SELL	$75.14 - $115.68 $3.69 Million - $5.68 Million	-49,135 Reduced 6.96%	657,205 $52.8 Million
Q4 2019 Feb 14, 2020	SELL	$100.29 - $107.99 $6.15 Million - $6.62 Million	-61,309 Reduced 7.99%	706,340 $75.4 Million
Q3 2019 Nov 14, 2019	BUY	$97.85 - $107.42 $48.5 Million - $53.3 Million	496,119 Added 182.71%	767,649 $82.2 Million
Q2 2019 Aug 14, 2019	BUY	$85.18 - $101.94 $2.21 Million - $2.64 Million	25,916 Added 10.55%	271,530 $27.6 Million
Q1 2019 May 14, 2019	SELL	$80.68 - $89.92 $19.2 Million - $21.4 Million	-238,045 Reduced 49.22%	245,614 $22.1 Million
Q4 2018 Feb 14, 2019	SELL	$79.75 - $108.38 $83.1 Million - $113 Million	-1,041,900 Reduced 68.3%	483,659 $40.3 Million
Q3 2018 Nov 14, 2018	BUY	$105.42 - $114.99 $82.4 Million - $89.9 Million	781,703 Added 105.09%	1,525,559 $165 Million
Q2 2018 Aug 14, 2018	BUY	$97.35 - $113.14 $68.8 Million - $80 Million	706,933 Added 1914.61%	743,856 $81.8 Million
Q1 2018 May 15, 2018	BUY	$96.42 - $107.88 $2.28 Million - $2.55 Million	23,647 Added 178.12%	36,923 $3.7 Million
Q4 2017 Feb 14, 2018	BUY	$90.86 - $100.24 $538,254 - $593,821	5,924 Added 80.58%	13,276 $1.31 Million
Q3 2017 Nov 13, 2017	BUY	$91.96 - $108.35 $676,089 - $796,589	7,352	7,352 $691,000

Others Institutions Holding DGX

# of Institutions

924

Shares Held

94.6M

Call Options Held

379K

Put Options Held

354K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Quest Diagnostics Inc Transaction History